A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease
Clinical trial NCT02260674 · COMPLETED
Trial details
- NCT number
- NCT02260674
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.